Are you going to be at the International AIDS Conference (AIDS2018) in Amsterdam, or following from afar? Here’s how to connect with us.
Make Medicines Affordable will be at AIDS 2018, 22-28 July. You can find our ‘must see’ events, booths and poster exhibitions listed below, which we’ll either be attending, particpating in or hosting – in relation to increasing access to treatment.
Barriers to essential medicines affect us all, so during the conference we’ll be sharing our experiences and successful strategies to improve the current system, which denies millions of people their right to health.
We’ll be tweeting live from the conference. Follow @affordabledrugs
Tag us in your news if you want us to follow and share!
PHARMA LIES APP
We’re launching the Pharma Lies app at AIDS 2018.
During the conference you can visit pharmaceutical companies’ booths and see the facts that they don’t want you to.
Find out more or download the app on Apple or Android. If you install ahead of the conference, we’ll send you an alert during AIDS 2018 once the augmented reality experience is up and running! Follow #PharmaLies on Twitter.
SUNDAY 22 JULY
- ITPC’s Community Activist Summit | Pre-Conference | 10:00 – 16:45 | G106-107 |
Through panel discussions and interactive dialogue, activists will strategize and develop concrete next steps needed to effectively advocate for the right to health for ALL.
Follow along and join the action on Facebook and Twitter using #ActivistSummit!
MONDAY 23 JULY
- It’s time to test and treat differently | Satellite Session | 8:00 – 10:00 | Hall 11B |
Compare and contrast differentiated service delivery along the HIV care cascade from countries and communities.
- Frontiers in generic and low-cost ARVs in high-, middle-, and low- income countries: Four provocative questions | Major Industry Sponsor Satellite | 12:30 – 14:30 | Elicium 1 |
A series of presenters will present and debate, including Sergey Golovin, ITPC Russia, who will be answering the following question: Making sure middle-income countries are not left behind, Question: For many upper middle-income countries, Global Fund support is being phased out, and across the board MICs are facing high prices and patent barriers. Are MICs being left behind?
- IP Advocacy at Country Level: Where to Start From
MENA Networking Zone | 17:30 – 18:30 : Global Village, booth 519 |
Intellectual property issues may seem very technical and limited to a narrow group of experts. It is not easy at community level to determine where to start from to develop an effective advocacy strategy. ITPC-MENA developed a community-friendly tool to do a rapid assessment of national laws and policies on IP and their impact on access to medicines. In this session, the Tunisian Association Against AIDS (ATL), who successfully used the tool will share its experience. Presenters include Alia Amimi and Alim El Gaddari, ITPC-MENA, Pauline Londeix, Consultant, and Detrich Peeler, ITPC Global.
TUESDAY 24 JULY
- Safety of Dolutegravir in pregnancy: Late breaking findings, interpretations, and implications | Symposia Session | 11:00 – 12:30 | Elicium 2 | Hosted by IAS and chaired by ITPC’s Wame Mosime |
- Save our lives! Patent law reform efforts in South Africa, Argentina, Brazil and beyond | Presentation | 11:00 – 12:30 | Treatment Networking Zone, Global Village, Booth 529Presented by TAC, ABIA, FEGP and RedLAM.
- Cutting through the noise of AIDS 2018 | Press Conference | 13:00 – 13:45 | G109 |
Join us as we cut through the noise and unpack the issues behind some of the most divisive questions facing the fight against HIV today.
- A Free Trade Agreement and HIV walk into a bar… | Workshop | 14:30 – 17:00 | G102-103
Free trade agreements being negotiated in nearly every developing country may adversely impact access to affordable generic medicines. The workshop will highlight key features of FTAs that are of public health concern and showcase advocacy by PLHIV networks and other health groups.
Co-facilitators: Kajal Bhardwaj, Independent Lawyer, India; Shiba Phurailatpam, Asia Pacific Network of People Living with HIV/AIDS, Thailand; Matthew Kavanagh, Georgetown University, United States; Othoman Mellouk, ITPC, Morocco.
- Re-imagining health innovation that delivers for public value | Presentation | 16:00 – 17:00 | Treatment Networking Zone, Global Village, Booth 529
Presented by STOPAIDS, ABIA, RedLAM, DNDi
- Rapid access to new technology and reaching the unreached | 18:00-21:30 | F002-004 | ITPC |
Executive Director Solange Baptiste speaking on “Global health and impact on individual people’s life: What does delayed access really mean?”.
WEDNESDAY 25 JULY
- When promise meets reality: Debating the future of CD4 and viral load testing | Satellite Session | 7:00 – 8:30 | Hall 11A |
Featuring ITPC Executive Director Solange Baptiste speaking on community response and perspectives on CD4 and VL demand, use and scale-up.
- Treatment politics and financing in 2018 | 16:30 – 18:00 | Elicium 2 |
16:45 | Using TRIPS-flexibilities as a leverage to improve access to HIV and hepatitis C medicines in Ukraine. Presented by Sergiy Kondratyuk, All-Ukrainian Network of People Living with HIV/AIDS.
17:00 | America’s $10 billion overspend on sofosubvir-based hepatitis C treatment resulting from unmerited patents. Presented by Aaron Pattillo, Initiative for Medicines, Access and Knowledge, United States
- Reigniting the fight for access to medicines: Outcomes and recommendations from the 2018 global summit on intellectual property and access to medicines (GSIPA2M2018)
| Abstract Poster | Presented by Othoman Mellouk.
THURSDAY 26 JULY
- The politics of PrEP | Satellite Session | 11:00 – 12:30 | Elicium 2 |
Featuring ITPC IP and Access to Medicines Lead Othoman Mellouk speaking on striking the balance between ‘treat all’ and PrEP where we are ‘not treating all’.
- Meeting the challenge: Community financing for a sustained response |Oral Abstract Session | 13:00 – 14:00 | E102 |
Hear the latest in domestic financing and sustainability. Chaired by ITPC’s Wame Mosime.
FRIDAY 27 JULY
- AIDS 2018 pre-conference report back: Community Activist Summit | Rapporteur Session | 12:45 – 14:00 | The Forum |
Did you miss the #ActivistSummit? Don’t worry, we’ll be doing a full recap of everything that happened!
SEE YOU IN THE GLOBAL VILLAGE!
These are some of the community booths we’ll be visiting or presenting at in the Networking Zone.
Stop pharma’s threats to treatment access
A ‘must-visit’ booth in the Networking Zone. We’ll be there along with partners and allies, highlighting the impact of pharma’s abuse of the patent system and how communities are fighting back. We expect to attract mainstream media as well as other civil society organizations with the plans we have in store. View the programme and follow @affordabledrugs for updates.
The BAD PHARMA TOUR will leave this booth daily at 1pm!
- Do you think medicines are priced fairly?
- Do you think researching a new drug costs billions of dollars?
- Are you swallowing big pharma’s lies?
Join the walking tour through the rich suburbia of AIDS 2018. This authentic tour provides a rich history of lies, greed and corruption across the world. Meet your tour guide at the Treatment Networking Zone in the Global Village, Booth 529. 1-2pm every day!
The People Living with HIV Networking Zone
Visit telephone-style ‘booths’ and engage in dialogue on a range of topics. There will be a running comment wall where people can share ideas, poems and messages. A programme of events will run throughout the week, including a presentation from our partner in Ukraine: Patent law reform in the Eastern European, Asia Pacific and Latin American region: Challenges and opportunities, presented by Sergiy Kondratyuk from the All-Ukrainian Network of People Living with HIV/AIDS | Tuesday 24 July | 16:00 – 17:00 |
Ending the AIDS crisis in MENA
Visit the MENA networking zone for a packed programme highlighting the issues affecting key populations and their programmes in MENA in relation to the HIV, including the criminalization of key populations, gender-based violence, intellectual property barriers to access to medicines, the shortage of funding, sustainability, and the lack of research.
ITPC-MENA will present a session on Monday 23 July | 17:30 – 18: 30 | IP Advocacy at Country Level: Where to Start From?
Improving universal access to medicines, Argentina
Visit REDLAM’s booth for information on the negative impact of intellectual property (IP) barriers on access to medicines for HIV and Hep C, including evidence and results from research studies. There will be discussions, a photo exhibition, details on RedLAM’s free online capacity-building workshop, and much more.
We’ll be tweeting when these poster presentations are about to take place. Follow @affordabledrugs for live updates throughout the week.
- Reigniting the fight for access to medicines: Outcomes and recommendations from the 2018 global summit on intellectual property and access to medicines (GSIPA2M2018).
By ITPC. Presented by Othoman Mellouk.
- Does Brazil pays a fair price for TDF? Civil society struggle to guarantee the sustainability of access universal policies.
By the Interdisciplinary Brazilian AIDS Association, Working Group on Intellectual Property, Rio de Janeiro, Brazil. Presented by Pedro Villardi.
- Comparing compulsory and voluntary licenses in Brazil: Lessons from efavirenz and atazanavir cases.
By Associação Brasileira Interdisciplinar de AIDS, Grupo de Trabalho sobre Propriedade Intelectual, Rio de Janeiro, Brazil. Presented by Pedro Villardi.
- The role of civil society in shaping the political environment for the incorporation of new technologies in Brazil: The cases of dolutegravir and TDF/FTC.
By ABIA – Brazilian Interdisciplinary Aids Association, ABIA – Brazilian Interdisciplinary Aids Association, and GTPI, Rio de Janeiro, Brazil. Presented by Felipe de Carvalho.
- How AIDS advocacy supports universal health coverage.
By AIDS Access Foundation, Bangkok, Thailand. Presented by Sangsiri Teemanka.
- Success of inter-associative advocacy strategies for access to dolutegravir in Morocco.
By ALCS, Morocco, Coalition PLUS, France, ITPC. Presented by Morgane Ahmar.
Follow on Facebook and Twitter, and sign up for emails here.